SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001571049-17-008778
Filing Date
2017-12-29
Accepted
2017-12-29 16:19:00
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 tv482183-s3.htm S-3 191712
2 EXHIBIT 5.1 tv482183_ex5-1.htm EX-5.1 15314
3 EXHIBIT 23.1 tv482183_ex23-1.htm EX-23.1 2454
4 GRAPHIC image_001.jpg GRAPHIC 2320
5 GRAPHIC lg_novavax.jpg GRAPHIC 39085
  Complete submission text file 0001571049-17-008778.txt   267662
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-222365 | Film No.: 171282155
SIC: 2836 Biological Products, (No Diagnostic Substances)